Д. С. Орлов

770 total citations
25 papers, 608 citations indexed

About

Д. С. Орлов is a scholar working on Microbiology, Molecular Biology and Immunology. According to data from OpenAlex, Д. С. Орлов has authored 25 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Microbiology, 15 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Д. С. Орлов's work include Antimicrobial Peptides and Activities (19 papers), Protein Hydrolysis and Bioactive Peptides (8 papers) and Biochemical and Structural Characterization (8 papers). Д. С. Орлов is often cited by papers focused on Antimicrobial Peptides and Activities (19 papers), Protein Hydrolysis and Bioactive Peptides (8 papers) and Biochemical and Structural Characterization (8 papers). Д. С. Орлов collaborates with scholars based in Russia, Germany and United States. Д. С. Орлов's co-authors include О. В. Шамова, O. Yu. Golubeva, Robert I. Lehrer, Tung Nguyen, Maria S. Zharkova, Igor E. Eliseev, Oleg B. Chakchir, V. N. Kokryakov, Tatiana Pazina and Tatiana V. Ovchinnikova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Д. С. Орлов

23 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Д. С. Орлов Russia 13 387 358 128 78 59 25 608
Patricia Maturana Argentina 9 368 1.0× 380 1.1× 70 0.5× 99 1.3× 69 1.2× 10 634
Ramamourthy Gopal South Korea 14 455 1.2× 440 1.2× 101 0.8× 76 1.0× 99 1.7× 21 668
Serge Ruden Germany 7 349 0.9× 316 0.9× 51 0.4× 57 0.7× 72 1.2× 7 520
Melina Martínez Argentina 12 556 1.4× 518 1.4× 92 0.7× 114 1.5× 87 1.5× 19 793
Fernanda Guilhelmelli Brazil 6 359 0.9× 320 0.9× 85 0.7× 65 0.8× 47 0.8× 7 540
Silvia Fabiole Nicoletto Italy 6 507 1.3× 459 1.3× 114 0.9× 72 0.9× 102 1.7× 6 736
Nathália Vilela Brazil 8 345 0.9× 334 0.9× 75 0.6× 72 0.9× 48 0.8× 12 551
Dianne Moyles Canada 6 320 0.8× 305 0.9× 88 0.7× 62 0.8× 65 1.1× 8 564
Anselmo J. Otero‐González Cuba 17 344 0.9× 382 1.1× 65 0.5× 58 0.7× 102 1.7× 31 694

Countries citing papers authored by Д. С. Орлов

Since Specialization
Citations

This map shows the geographic impact of Д. С. Орлов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Д. С. Орлов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Д. С. Орлов more than expected).

Fields of papers citing papers by Д. С. Орлов

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Д. С. Орлов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Д. С. Орлов. The network helps show where Д. С. Орлов may publish in the future.

Co-authorship network of co-authors of Д. С. Орлов

This figure shows the co-authorship network connecting the top 25 collaborators of Д. С. Орлов. A scholar is included among the top collaborators of Д. С. Орлов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Д. С. Орлов. Д. С. Орлов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zharkova, Maria S., Maria Khaydukova, Stanislav S. Terekhov, et al.. (2024). First vertebrate BRICHOS antimicrobial peptides: β-hairpin host defense peptides in limbless amphibia lung resemble those of marine worms. Biochemical and Biophysical Research Communications. 712-713. 149913–149913.
2.
Шамова, О. В., et al.. (2021). Epididymal antimicrobial peptides: the role in sperm function (review). 4–12.
3.
Орлов, Д. С., et al.. (2021). Peptides of the innate immunity as potential anticancer agents: pros and cons. SHILAP Revista de lepidopterología. 23(6). 1285–1306. 1 indexed citations
4.
Zharkova, Maria S., Maria Smirnova, V. N. Kokryakov, et al.. (2020). Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs. Frontiers in Cellular and Infection Microbiology. 10. 552905–552905. 18 indexed citations
5.
Шамова, О. В., et al.. (2020). Hemolitic Activity and Sorption Ability of Beta Zeolite Nanoparticles. Glass Physics and Chemistry. 46(2). 155–161. 6 indexed citations
8.
Zharkova, Maria S., Д. С. Орлов, O. Yu. Golubeva, et al.. (2019). Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics—A Novel Way to Combat Antibiotic Resistance?. Frontiers in Cellular and Infection Microbiology. 9. 128–128. 205 indexed citations
9.
Zharkova, Maria S., et al.. (2018). EFFECTS OF PROLINE-RICH PEPTIDES OF THE INNATE IMMUNE SYSTEM ON DRUG-RESISTANT BACTERIAL STRAINS. Medical Immunology (Russia). 20(1). 107–114. 2 indexed citations
10.
Müller, Anna, Fabian Grein, Andreas Otto, et al.. (2017). Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. International Journal of Medical Microbiology. 308(3). 335–348. 36 indexed citations
12.
Balandin, Sergey V., Ilia A. Bolosov, Pavel V. Panteleev, et al.. (2016). INTERNALIZATION OF ANTIMICROBIAL PEPTIDE ACIPENSIN 1 INTO HUMAN TUMOR CELLS. Medical Immunology (Russia). 18(6). 575–582. 2 indexed citations
13.
Шамова, О. В., Д. С. Орлов, Sergey V. Balandin, et al.. (2016). Minibactenecins ChBac7.Nα and ChBac7. Nβ - Antimicrobial Peptides from Leukocytes of the Goat Capra hircus.. Acta Naturae. 8(3). 136–146. 23 indexed citations
14.
Орлов, Д. С., et al.. (2014). IMMUNOMODULATORY ACTIVITY OF ANTIMICROBIAL PEPTIDE INDOLICIDIN AND ITS STRUCTURAL ANALOGUES. Medical Immunology (Russia). 11(1). 101–101. 5 indexed citations
15.
Шамова, О. В., Д. С. Орлов, Sergey V. Balandin, et al.. (2014). Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii. Acta Naturae. 6(4). 99–109. 22 indexed citations
16.
Golubeva, O. Yu., О. В. Шамова, Д. С. Орлов, et al.. (2011). Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics. Glass Physics and Chemistry. 37(1). 78–84. 24 indexed citations
17.
Шамова, О. В., Д. С. Орлов, Christin Stegemann, et al.. (2009). ChBac3.4: A Novel Proline-Rich Antimicrobial Peptide from Goat Leukocytes. International Journal of Peptide Research and Therapeutics. 15(2). 107–119. 15 indexed citations
18.
Орлов, Д. С., Tung Nguyen, & Robert I. Lehrer. (2002). Potassium release, a useful tool for studying antimicrobial peptides. Journal of Microbiological Methods. 49(3). 325–328. 81 indexed citations
19.
Zhao, Chengquan, Tung Nguyen, Lee Ming Boo, et al.. (2001). RL-37, an Alpha-Helical Antimicrobial Peptide of the Rhesus Monkey. Antimicrobial Agents and Chemotherapy. 45(10). 2695–2702. 55 indexed citations
20.
Корнева, Е. А., et al.. (1997). Interleukin‐1 and Defensins in Thermoregulation, Stress, and Immunitya. Annals of the New York Academy of Sciences. 813(1). 465–473. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026